About Kate Therapeutics
Kate Therapeutics is a company based in San Diego (United States) founded in 2020 was acquired by Novartis in November 2024.. Kate Therapeutics has raised $123.78 million across 4 funding rounds from investors including Novartis, University of Florida and Westlake BioPartners. The company has 46 employees as of December 31, 2022. Kate Therapeutics operates in a competitive market with competitors including Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and AskBio, among others.
- Headquarter San Diego, United States
- Employees 46 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kate Therapeutics Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Kate Therapeutics
Kate Therapeutics has successfully raised a total of $123.78M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $21.78 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $21.8M
-
First Round
First Round
(05 Feb 2021)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series A - Kate Therapeutics | Valuation |
investors |
|
| Jun, 2023 | Amount | Series A - Kate Therapeutics | Valuation | Westlake Village Biopartners , Versant Ventures | |
| Aug, 2021 | Amount | Series A - Kate Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kate Therapeutics
Kate Therapeutics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, University of Florida and Westlake BioPartners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Westlake BioPartners is engaged in biotech venture capital investment.
|
Founded Year | Domain | Location | |
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location | |
|
Early- to growth-stage startups are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kate Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Kate Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kate Therapeutics Comparisons
Competitors of Kate Therapeutics
Kate Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and AskBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Muscle activators are developed for debilitating diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kate Therapeutics
Frequently Asked Questions about Kate Therapeutics
When was Kate Therapeutics founded?
Kate Therapeutics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Kate Therapeutics located?
Kate Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Kate Therapeutics a funded company?
Kate Therapeutics is a funded company, having raised a total of $123.78M across 4 funding rounds to date. The company's 1st funding round was a Series A of $35M, raised on Feb 05, 2021.
How many employees does Kate Therapeutics have?
As of Dec 31, 2022, the latest employee count at Kate Therapeutics is 46.
What does Kate Therapeutics do?
Kate Therapeutics was founded in 2020 and is headquartered in San Diego, United States. AAV-based gene therapies are developed by the company to target genetically defined muscle diseases within the biotechnology sector. Operations are concentrated on research and preclinical advancement of these therapies. Focus is maintained on addressing unmet needs in neuromuscular disorders through viral vector technologies.
Who are the top competitors of Kate Therapeutics?
Kate Therapeutics's top competitors include Vaxcyte, Serum Institute of India and Biological E.
Who are Kate Therapeutics's investors?
Kate Therapeutics has 5 investors. Key investors include Novartis, University of Florida, Westlake BioPartners, Versant Ventures, and Osage University Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.